Business Context and Reporting Period
This Form 8-K was filed by Palisade Bio, Inc. on May 5, 2021, reporting events occurring on that date. The filing addresses the completion of a share reconciliation by the company's transfer agent following a reverse stock split and a merger transaction.
Key Financial Metrics
This filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure adjustments related to a merger.
Material Changes
- Share Reconciliation: The transfer agent completed the reconciliation of fractional shares resulting from a reverse stock split effected on April 27, 2021.
- Outstanding Shares: Immediately following the Effective Time of the Merger Agreement, there were 7,302,040 shares of Common Stock outstanding.
- Escrowed Shares: An additional 3,977,676 shares (Converted Additional Shares) are held in escrow. These shares are subject to issuance to an investor in a financing transaction or cancellation within 135 days.
- Merger Context: The events relate to the Agreement and Plan of Merger dated December 16, 2020, involving Palisade Bio, Inc., Leading Biosciences, Inc. (LBS), and Townsgate Acquisition Sub 1, Inc.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the mechanics of the share escrow. The primary contingency noted is the potential cancellation of escrowed shares if they are not issued to the financing investor, which would trigger the issuance of an equivalent number of shares to former LBS stockholders.
Investor Verification Checklist
- Verify the final status of the 3,977,676 escrowed shares (issued vs. cancelled) within the 135-day window.
- Confirm the total fully diluted share count once the escrow contingency is resolved.
- Review the terms of the financing transaction that closed on April 27, 2021, to understand the conditions for issuing the escrowed shares.
- Check subsequent filings for the impact of the reverse stock split on historical financial data.